FindTrial
Sign In

Clinical Interest of a Genetic Diagnosis in Early Infant Epilepsy, Paraclinical and Therapeutic Management, and Psychological Impact of Families

Clinical Interest of a Genetic Diagnosis in Early Infant Epilepsy, Paraclinical and Therapeutic Management, and Psychological Impact of Families

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05455333
Enrollment
75
Registered
2022-07-13
Start date
2022-08-31
Completion date
2022-12-31
Last updated
2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Infant Epilepsy

Brief summary

To determine the paraclinical and therapeutic interest of genetic diagnosis in early onset epilepsy.

Interventions

OTHERQuestionnaires

Sends and returns questionnaires to families.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children aged ≤ 12 years, * hospitalized or followed at the Hautepierre Hospital of the University Hospitals of Strasbourg for primary epilepsy having started in the first 5 months of life, from 2010 to 2021.

Exclusion criteria

\- Children with secondary epilepsy (with infection trauma)

Design outcomes

Primary

MeasureTime frameDescription
Measurement of event densities4 monthThe frequency of events (crises, going to the emergency room, hospitalizations) before and after genetic diagnosis.

Countries

France

Contacts

Primary ContactAnaïs PHILIPPE
Anais.philippe@chru-strasbourg.fr+33 3 69 55 19 55
Backup ContactMarie Thérèse ABI WARDE
Marie-therese.abiwarde@chru-strasbourg.fr+33 3 88 12 84 61

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026